BEDFORD, Mass., July 12 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will present at the Canaccord Genuity 30th Annual Growth Conference 2010 on Wednesday, August 11, 2010 at 1:00 p.m. (Eastern).
Interested parties are invited to listen to the live audio webcast of Hologic’s investor presentation on the investor section of the company’s website at www.hologic.com/investor-overview. An archive of the presentation will be available for replay following the conference.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic’s core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.
Contact: | Deborah Gordon | |
Vice President, Investor Relations | ||
Hologic, Inc. | ||
(781) 999-7716 | ||
SOURCE Hologic, Inc.
